Ann: Dimerix Announces License Agreement for EU, Canada, ANZ, page-377

Ps. No I’m not worried about it. There is probably no reason DMX-200 could not be an adjunct therapy, just like SGLT2 inhibitors and older diabetes drugs like Metformin. I will spend some time catching up on research over the coming weeks though. An ever evolving space. It had to happen, with both Diabetes & CKD & a WHO recognised endemic disease globally. I have posted a lot of stuff over the years, so maybe go back & take a look at what might be helpful to you, but times & research has changed treatment now for the better.